Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Redcare Pharmacy NV (RDC)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
129.100 +3.700    +2.95%
03/05 - Closed. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  Germany
ISIN:  NL0012044747 
WKN:  A2AR94
  • Volume: 51,619
  • Bid/Ask: 129.000 / 129.200
  • Day's Range: 125.000 - 130.000
Redcare Pharmacy NV 129.100 +3.700 +2.95%

RDC Recent Sentiments

 
This page contains information on users’ sentiments for the Redcare Pharmacy NV stock, which are displayed both on charts of different periods of time and on a detailed table.
BearishBullish
Start Date Username Call Open Rate End Date Chg. %
Apr 24, 2024 Abc Abc   139.800 Apr 29, 2024 @ 128.500 -8.08%
Apr 19, 2024 Sven Kipnich   128.200 +0.70%
Apr 15, 2024 Thomas Frank   135.000 +4.37%
Apr 11, 2024 paulo mascarenhas   135.100 May 03, 2024 @ 129.100 -4.44%
Apr 08, 2024 Abc Abc   149.500 Apr 15, 2024 @ 136.000 -9.03%
Mar 28, 2024 Matteo Dolfi   152.300 Apr 19, 2024 @ 129.000 -15.30%
Mar 27, 2024 Abc Abc   147.000 Apr 01, 2024 @ 151.650 +3.16%
Mar 15, 2024 Per Bjorgell   140.450 Apr 05, 2024 @ 149.100 +6.16%
Mar 13, 2024 Kristijan Knezevic   131.250 Mar 18, 2024 @ 140.850 +7.31%
Mar 07, 2024 Vanessa Schnabel   123.700 Mar 29, 2024 @ 151.650 +22.59%
Mar 07, 2024 Burkhard Gehde   125.750 Mar 29, 2024 @ 151.650 +20.60%
Mar 05, 2024 Silvia Roloff   132.400 Mar 29, 2024 @ 151.650 +14.54%
Mar 01, 2024 Roland Schnoewitz   137.350 Mar 04, 2024 @ 129.000 -6.08%
Feb 29, 2024 Chr Linkus   140.400 Mar 22, 2024 @ 145.200 -3.42%
Feb 20, 2024 Thomas Frank   140.150 Mar 15, 2024 @ 141.000 +0.61%
Feb 16, 2024 Roland Schnoewitz   145.300 Feb 19, 2024 @ 144.650 -0.45%
Feb 15, 2024 James Musk   145.250 Mar 08, 2024 @ 120.900 -16.76%
Feb 13, 2024 Norbert Siedler   146.800 Mar 08, 2024 @ 120.900 -17.64%
Feb 05, 2024 Rainer Weißbach   140.200 Feb 12, 2024 @ 149.000 +6.28%
Jan 25, 2024 Thomas Frank   135.050 Feb 16, 2024 @ 145.800 +7.96%
Jan 22, 2024 Silvia Roloff   126.200 Feb 16, 2024 @ 145.800 +15.53%
Jan 17, 2024 Christian Gehring   120.750 Feb 09, 2024 @ 145.350 +20.37%
Jan 17, 2024 James Musk   120.500 Feb 09, 2024 @ 145.350 +20.62%
Jan 10, 2024 Torsten Schmidt   137.950 Feb 02, 2024 @ 133.150 -3.48%
Jan 05, 2024 Simon Harder   136.350 Jan 08, 2024 @ 140.000 +2.68%
Dec 27, 2023 Silvia Roloff   133.450 Jan 19, 2024 @ 127.700 -4.31%
Dec 21, 2023 James Musk   133.500 Jan 12, 2024 @ 128.650 -3.63%
Dec 07, 2023 Thomas Frank   134.600 Dec 29, 2023 @ 131.600 -2.23%
Dec 06, 2023 Kristijan Knezevic   134.600 Dec 11, 2023 @ 135.050 +0.33%
Dec 06, 2023 Florian Aichhorn   129.200 Dec 29, 2023 @ 131.600 +1.86%
Nov 23, 2023 Torsten Schmidt   122.550 Dec 15, 2023 @ 134.850 +10.04%
Nov 08, 2023 Burkhard Gehde   107.850 Dec 01, 2023 @ 126.250 +17.06%
Nov 07, 2023 René Jacob   107.300 Dec 01, 2023 @ 126.250 +17.66%
Oct 31, 2023 Uwe Illig   105.700 Nov 30, 2023 @ 128.350 +21.43%
Oct 31, 2023 Torsten Brauer   103.700 Nov 30, 2023 @ 128.350 +23.77%
Oct 30, 2023 Kristijan Knezevic   104.200 Nov 30, 2023 @ 128.350 +23.18%
Oct 24, 2023 Paul eta   114.850 Nov 30, 2023 @ 128.350 +11.75%
Oct 11, 2023 Detlef Kork   112.150 Nov 30, 2023 @ 128.350 +14.44%
Oct 06, 2023 Werner Schmidt   109.900 Nov 30, 2023 @ 128.350 +16.79%
Oct 05, 2023 Nicolas Schoch   106.500 Nov 30, 2023 @ 128.350 +20.52%
Oct 05, 2023 Angela Kunze   106.800 Nov 30, 2023 @ 128.350 +20.18%
Sep 29, 2023 Florian Aichhorn   101.500 Nov 30, 2023 @ 128.350 +26.45%
Sep 29, 2023 Kristian kappa   101.000 Nov 30, 2023 @ 128.350 +27.08%
Sep 27, 2023 Timo Müller   97.480 Nov 30, 2023 @ 128.350 +31.67%
Sep 22, 2023 Mia Seibel   97.940 Nov 30, 2023 @ 128.350 +31.05%
Aug 31, 2023 Lounes Kahouadji   108.900 Nov 30, 2023 @ 128.350 +17.86%
Aug 01, 2023 Jacqueline Jungnitsvh   105.600 Nov 30, 2023 @ 128.350 +21.54%
Jul 06, 2023 Vanessa Schnabel   102.250 Nov 30, 2023 @ 128.350 +25.53%
Jun 14, 2023 Yasmina Raupova   88.300 Nov 30, 2023 @ 128.350 +45.36%
Jun 12, 2023 P M   86.360 Jun 12, 2023 @ 86.360 0.00%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

RDC Comments

Write your thoughts about Redcare Pharmacy NV
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
BELLA ITALIA
BELLA ITALIA Jul 08, 2021 7:55AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
.....and In his latest research note, analyst Gerhard Orgonas confirms his positive recommendation. The broker Berenberg is keeping its Buy rating. The target price is reduced from EUR 230 to EUR 215.
Jul 08, 2021 7:55AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
why reduced?
NY Brokers Stock Exchange
NY Brokers Stock Exchange Jul 08, 2021 7:55AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
are you sure please ?
BELLA ITALIA
BELLA ITALIA Jul 08, 2021 7:36AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
good..now the title will just have to go up, PRESS RELEASE : SHOP APOTHEKE EUROPE Growth in Q2 temporarily decelerated to 7.3%, but Preliminary sales grew by 14.9% during the first six months of 2021.
BELLA ITALIA
BELLA ITALIA Jul 08, 2021 7:29AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Great title! Despite the decline in recent periods, according to Warburg Research analyst Michael Heider, he continues to maintain his recommendation on the stock with a Neutral rating. The target price continues to be set at 179 euros. marketscreener. com / quote / stock / SHOP-APOTHEKE-EUROPE-N-V-31620967 / news / SHOP-APOTHEKE-EUROPE-NV-nbsp-Warburg-Research-sticks-Neutral-35805419 /
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email